Contact
searchSearch
HMP Global

Esophageal Diseases and Disorders Topic Center

Featured Article

Research Highlights
High Prevalence of Gut-Brain Interaction Disorders Found in Patients With Refractory Reflux Symptoms
06/24/2025
Jessica Garlewicz
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this...
06/24/2025
Gastroenterology
News
FDA Approves Budesonide Oral Suspension for EoE
02/28/2024
Rebecca Mashaw
The approval marks the first and only oral therapy for patients 11 and older with eosinophilic esophagitis.
The approval marks the first and only oral therapy for patients 11 and older with eosinophilic esophagitis.
The approval marks the first and...
02/28/2024
Gastroenterology
News
The Link Between Nonerosive Gastroesophageal Reflux and Esophageal Cancer
01/26/2024
Priyam Vora
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general...
01/26/2024
Gastroenterology
News
Researchers Evaluate Risk Factors for Nonerosive GERD, Functional Dyspepsia
01/01/2024
Jolynn Tumolo
Male sex, alcohol use, and calcium channel blockers linked to erosive esophagitis.
Male sex, alcohol use, and calcium channel blockers linked to erosive esophagitis.
Male sex, alcohol use, and...
01/01/2024
Gastroenterology
Conference Coverage
Prasad Iyer, MD, Reviews Tips for Managing Barrett’s Esophagus
12/24/2023
Priyam Vora
Dr Prasad Iyer reviewed evolving treatments for Barrett’s esophagus and how to use them in clinical setting.
Dr Prasad Iyer reviewed evolving treatments for Barrett’s esophagus and how to use them in clinical setting.
Dr Prasad Iyer reviewed evolving...
12/24/2023
Gastroenterology
Conference Coverage
Beyond PPIs: Evan S. Dellon, MD, on Approaches Treating to EoE
12/22/2023
Evan S. Dellon, MD
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
Treatment of eosinophilic...
12/22/2023
Gastroenterology
News
FDA Approves Vonoprazan for Erosive Esophagitis
11/02/2023
Vonoprazan is already approved for treatment of Helicobacter pylori.
Vonoprazan is already approved for treatment of Helicobacter pylori.
Vonoprazan is already approved...
11/02/2023
Gastroenterology
Rena Yadlapati
Conference Coverage
Rena Yadlapati, MD, on the Difficult-to-Treat Patient With GERD
10/23/2023
Rena Yadlapati, MD
Dr Yadlapati provides guidance in the options for caring for patients who present with GERD that does not respond adequately to treatment.
Dr Yadlapati provides guidance in the options for caring for patients who present with GERD that does not respond adequately to treatment.
Dr Yadlapati provides guidance...
10/23/2023
Gastroenterology
News
Patient Response to Corticosteroids for EoE May Be Tied to BMI
09/27/2023
Priyam Vora
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a...
09/27/2023
Gastroenterology
News
A Fresh Look at Incidence and Prevalence of EoE
08/23/2023
Rebecca Mashaw
What did the expansion of diagnostic criteria for eosinophilic esophagitis reveal about the true prevalence and incidence?
What did the expansion of diagnostic criteria for eosinophilic esophagitis reveal about the true prevalence and incidence?
What did the expansion of...
08/23/2023
Gastroenterology
Conference Coverage
NO to Opioids to Improve Esophageal Dysmotility
08/08/2023
Priyam Vora
Chengu Niu, MD, explored the adverse effects of opioids on esophageal motility, in his abstract presentation at the DDW 2023.
Chengu Niu, MD, explored the adverse effects of opioids on esophageal motility, in his abstract presentation at the DDW 2023.
Chengu Niu, MD, explored the...
08/08/2023
Gastroenterology

News

Research Highlights
High Prevalence of Gut-Brain Interaction Disorders Found in Patients With Refractory Reflux Symptoms
06/24/2025
Jessica Garlewicz
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this...
06/24/2025
Gastroenterology
News
The Link Between Nonerosive Gastroesophageal Reflux and Esophageal Cancer
01/26/2024
Priyam Vora
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general...
01/26/2024
Gastroenterology
News
Researchers Evaluate Risk Factors for Nonerosive GERD, Functional Dyspepsia
01/01/2024
Jolynn Tumolo
Male sex, alcohol use, and calcium channel blockers linked to erosive esophagitis.
Male sex, alcohol use, and calcium channel blockers linked to erosive esophagitis.
Male sex, alcohol use, and...
01/01/2024
Gastroenterology
News
FDA Approves Vonoprazan for Erosive Esophagitis
11/02/2023
Vonoprazan is already approved for treatment of Helicobacter pylori.
Vonoprazan is already approved for treatment of Helicobacter pylori.
Vonoprazan is already approved...
11/02/2023
Gastroenterology
News
Patient Response to Corticosteroids for EoE May Be Tied to BMI
09/27/2023
Priyam Vora
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a...
09/27/2023
Gastroenterology
News
A Fresh Look at Incidence and Prevalence of EoE
08/23/2023
Rebecca Mashaw
What did the expansion of diagnostic criteria for eosinophilic esophagitis reveal about the true prevalence and incidence?
What did the expansion of diagnostic criteria for eosinophilic esophagitis reveal about the true prevalence and incidence?
What did the expansion of...
08/23/2023
Gastroenterology
doctor chart general
News
Erosive Esophagitis Needs Fast-Acting New Treatments
05/20/2023
Management of erosive esophagitis was found to be generally suboptimal, according to a recent multicenter study.
Management of erosive esophagitis was found to be generally suboptimal, according to a recent multicenter study.
Management of erosive...
05/20/2023
Gastroenterology
Conference Coverage
Evan Dellon, MD, on Dupilumab for Eosinophilic Esophagitis
03/30/2023
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper...
03/30/2023
Gastroenterology
News
Is Vonoprazan Effective in Healing Erosive Esophagitis?
11/02/2022
Researchers investigated vonoprazan as an effective alternative to lansoprazole for treating patients with erosive esophagitis.
Researchers investigated vonoprazan as an effective alternative to lansoprazole for treating patients with erosive esophagitis.
Researchers investigated...
11/02/2022
Gastroenterology
News
Observing Guidelines for GERD Can Reduce Symptoms in Women
09/29/2022
The Nurses’ Health Study shows that regular exercise and dietary changes can help some patients avoid medication for gastroesophageal reflux disease.
The Nurses’ Health Study shows that regular exercise and dietary changes can help some patients avoid medication for gastroesophageal reflux disease.
The Nurses’ Health Study shows...
09/29/2022
Gastroenterology
Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
Emerging Therapies
EC Plus FOLFIRI Improves Response Rates in First-Line BRAF V600E–Mutant Metastatic Colorectal Cancer
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology
Research Highlights
Short Course Radiation and ctDNA for Rectal Cancer
01/14/2026
Jessica Garlewicz
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the...
01/14/2026
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
01/14/2026
Jessica Garlewicz
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
01/14/2026
Gastroenterology
Research Highlights
Persistent MASLD Greatly Increases Diabetes and Cardiovascular Risks, Study Finds
12/15/2025
Rebecca Mashaw
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links...
12/15/2025
Gastroenterology
Research Highlights
Sex-Specific Risks Highlight MASLD Burden Across Women’s Lifespan
12/11/2025
Rebecca Mashaw
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD...
12/11/2025
Gastroenterology
Conference Coverage
Resmetirom Reduces Portal Hypertension Risk and Fibrosis Markers in MASH Cirrhosis at 2 Years
11/04/2025
Jessica Garlewicz
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients...
11/04/2025
Gastroenterology
Conference Coverage
Tirzepatide Bests Semaglutide in Reducing Cardiovascular Events and Mortality in Patients With MASLD/MASH
11/04/2025
Jessica Garlewicz
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was...
11/04/2025
Gastroenterology
Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
Research Highlights
Liquid Biopsy Shows Potential in Cholangiocarcinoma Care
10/09/2025
Rebecca Mashaw
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights...
10/09/2025
Gastroenterology

Interactive

Quiz
Pop Quiz: Progression of Barrett esophagus
12/07/2018
Take our quiz on patients with Barrett esophagus and see how you do!
Take our quiz on patients with Barrett esophagus and see how you do!
Take our quiz on patients with...
12/07/2018
Gastroenterology
Quiz
McKeown-MIE vs McKeown-OE
07/08/2011
Which treatment was associated with better long-term survival outcomes for patients with esophageal cancer? Take our quiz and find out!
Which treatment was associated with better long-term survival outcomes for patients with esophageal cancer? Take our quiz and find out!
Which treatment was associated...
07/08/2011
Gastroenterology
Quiz
Diagnostic Complexity in Refractory GERD
08/07/2025
Rebecca Mashaw
What did researchers find in a recent study of patients with GERD and persistent reflux symptoms despite PPI therapy? Take our quick quiz to find out!
What did researchers find in a recent study of patients with GERD and persistent reflux symptoms despite PPI therapy? Take our quick quiz to find out!
What did researchers find in a...
08/07/2025
Gastroenterology
Quiz
Terminal Ileal Resection and CRC Risk
08/07/2025
Rebecca Mashaw
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in...
08/07/2025
Gastroenterology
Quiz
DGBIs and GERD
08/07/2025
Rebecca Mashaw
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
Is there any association between...
08/07/2025
Gastroenterology
News
Prevalence of Overlapping Esophageal DGBIs and GERD in Patients With Refractory Reflux
08/01/2025
Rebecca Mashaw
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that...
08/01/2025
Gastroenterology
Quiz
How Does Stool-Based CRC Surveillance Compare to Colonoscopy?
07/21/2025
Rebecca Mashaw
07/21/2025
Gastroenterology
Quiz
How Does CRC Affect Sexual Health in Women Over 40?
07/21/2025
Rebecca Mashaw
07/21/2025
Gastroenterology
Quiz
How Does CRC Affect Sexual Health in Women Under 40?
07/21/2025
Rebecca Mashaw
07/21/2025
Gastroenterology
Quiz
What Improves FIT Return Rates?
07/18/2025
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
The TEMPO trial investigated...
07/18/2025
Gastroenterology
Quiz
Social Determinants of Health and MASLD/MASH
07/18/2025
Rebecca Mashaw
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several...
07/18/2025
Gastroenterology
Quiz
MASLD in 2050
07/18/2025
Rebecca Mashaw
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of...
07/18/2025
Gastroenterology

News

Research Highlights
High Prevalence of Gut-Brain Interaction Disorders Found in Patients With Refractory Reflux Symptoms
06/24/2025
Jessica Garlewicz
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this...
06/24/2025
Gastroenterology
News
The Link Between Nonerosive Gastroesophageal Reflux and Esophageal Cancer
01/26/2024
Priyam Vora
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general...
01/26/2024
Gastroenterology
News
Researchers Evaluate Risk Factors for Nonerosive GERD, Functional Dyspepsia
01/01/2024
Jolynn Tumolo
Male sex, alcohol use, and calcium channel blockers linked to erosive esophagitis.
Male sex, alcohol use, and calcium channel blockers linked to erosive esophagitis.
Male sex, alcohol use, and...
01/01/2024
Gastroenterology
News
FDA Approves Vonoprazan for Erosive Esophagitis
11/02/2023
Vonoprazan is already approved for treatment of Helicobacter pylori.
Vonoprazan is already approved for treatment of Helicobacter pylori.
Vonoprazan is already approved...
11/02/2023
Gastroenterology
News
Patient Response to Corticosteroids for EoE May Be Tied to BMI
09/27/2023
Priyam Vora
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a...
09/27/2023
Gastroenterology
News
A Fresh Look at Incidence and Prevalence of EoE
08/23/2023
Rebecca Mashaw
What did the expansion of diagnostic criteria for eosinophilic esophagitis reveal about the true prevalence and incidence?
What did the expansion of diagnostic criteria for eosinophilic esophagitis reveal about the true prevalence and incidence?
What did the expansion of...
08/23/2023
Gastroenterology
doctor chart general
News
Erosive Esophagitis Needs Fast-Acting New Treatments
05/20/2023
Management of erosive esophagitis was found to be generally suboptimal, according to a recent multicenter study.
Management of erosive esophagitis was found to be generally suboptimal, according to a recent multicenter study.
Management of erosive...
05/20/2023
Gastroenterology
Conference Coverage
Evan Dellon, MD, on Dupilumab for Eosinophilic Esophagitis
03/30/2023
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper...
03/30/2023
Gastroenterology
News
Is Vonoprazan Effective in Healing Erosive Esophagitis?
11/02/2022
Researchers investigated vonoprazan as an effective alternative to lansoprazole for treating patients with erosive esophagitis.
Researchers investigated vonoprazan as an effective alternative to lansoprazole for treating patients with erosive esophagitis.
Researchers investigated...
11/02/2022
Gastroenterology
News
Observing Guidelines for GERD Can Reduce Symptoms in Women
09/29/2022
The Nurses’ Health Study shows that regular exercise and dietary changes can help some patients avoid medication for gastroesophageal reflux disease.
The Nurses’ Health Study shows that regular exercise and dietary changes can help some patients avoid medication for gastroesophageal reflux disease.
The Nurses’ Health Study shows...
09/29/2022
Gastroenterology
Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
Emerging Therapies
EC Plus FOLFIRI Improves Response Rates in First-Line BRAF V600E–Mutant Metastatic Colorectal Cancer
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology
Research Highlights
Short Course Radiation and ctDNA for Rectal Cancer
01/14/2026
Jessica Garlewicz
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the...
01/14/2026
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
01/14/2026
Jessica Garlewicz
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
01/14/2026
Gastroenterology
Research Highlights
Persistent MASLD Greatly Increases Diabetes and Cardiovascular Risks, Study Finds
12/15/2025
Rebecca Mashaw
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links...
12/15/2025
Gastroenterology
Research Highlights
Sex-Specific Risks Highlight MASLD Burden Across Women’s Lifespan
12/11/2025
Rebecca Mashaw
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD...
12/11/2025
Gastroenterology
Conference Coverage
Resmetirom Reduces Portal Hypertension Risk and Fibrosis Markers in MASH Cirrhosis at 2 Years
11/04/2025
Jessica Garlewicz
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients...
11/04/2025
Gastroenterology
Conference Coverage
Tirzepatide Bests Semaglutide in Reducing Cardiovascular Events and Mortality in Patients With MASLD/MASH
11/04/2025
Jessica Garlewicz
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was...
11/04/2025
Gastroenterology
Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
Research Highlights
Liquid Biopsy Shows Potential in Cholangiocarcinoma Care
10/09/2025
Rebecca Mashaw
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights...
10/09/2025
Gastroenterology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use